The BC-819 plasmid used consisted of a double-stranded DNA construct carrying the H19 promoter sequence and the diphtheria toxin A DNA, and was intended to be expressed in cancer cells, which usually express H19 at high levels. The gene discussed is H19; the disease is cancer.